{
    "Trade/Device Name(s)": [
        "SuperCheck Plus Blood Glucose Monitoring System (Model 5228-S)",
        "SuperCheck Plus Multi Blood Glucose Monitoring System (Model 5228-M)"
    ],
    "Submitter Information": "Biotest Medical Corporation",
    "510(k) Number": "K141351",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070585"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "May 20, 2014",
    "Summary Letter Received Date": "May 22, 2014",
    "Submission Date": "May 14, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "SuperCheck Plus Blood Glucose Meter",
        "SuperCheck Plus Multi Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method"
    ],
    "Methodologies": [
        "Enzyme electrochemical detection"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for SuperCheck Plus blood glucose monitoring systems for quantitative measurement of blood glucose in whole blood specimens",
    "Indications for Use Summary": "For self-testing or professional use as an aid to monitor effectiveness of diabetes control programs, measuring glucose in fresh capillary whole blood from fingertip or forearm (Model 5228-S for single-user home testing, Model 5228-M for multiple-patient use in healthcare settings; not for diagnosis, screening, or neonatal use)",
    "fda_folder": "Clinical Chemistry"
}